AU666176B2 - Mammalian expression systems for HCV proteins - Google Patents

Mammalian expression systems for HCV proteins Download PDF

Info

Publication number
AU666176B2
AU666176B2 AU36049/93A AU3604993A AU666176B2 AU 666176 B2 AU666176 B2 AU 666176B2 AU 36049/93 A AU36049/93 A AU 36049/93A AU 3604993 A AU3604993 A AU 3604993A AU 666176 B2 AU666176 B2 AU 666176B2
Authority
AU
Australia
Prior art keywords
leu
ala
thr
pro
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU36049/93A
Other languages
English (en)
Other versions
AU3604993A (en
Inventor
Suzanne L Bode
James M. Casey
Suresh M. Desai
Sushil G. Devare
Donald E. Frail
Julie Yamaguchi
Billy J Zeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU3604993A publication Critical patent/AU3604993A/en
Application granted granted Critical
Publication of AU666176B2 publication Critical patent/AU666176B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU36049/93A 1992-01-31 1993-01-29 Mammalian expression systems for HCV proteins Expired - Fee Related AU666176B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US830024 1986-02-14
US83002492A 1992-01-31 1992-01-31
PCT/US1993/000907 WO1993015193A1 (en) 1992-01-31 1993-01-29 Mammalian expression systems for hcv proteins

Publications (2)

Publication Number Publication Date
AU3604993A AU3604993A (en) 1993-09-01
AU666176B2 true AU666176B2 (en) 1996-02-01

Family

ID=25256134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36049/93A Expired - Fee Related AU666176B2 (en) 1992-01-31 1993-01-29 Mammalian expression systems for HCV proteins

Country Status (9)

Country Link
US (2) US5667992A (member.php)
EP (1) EP0627000B1 (member.php)
JP (1) JP3439209B2 (member.php)
AU (1) AU666176B2 (member.php)
CA (1) CA2129733C (member.php)
DE (1) DE69333269T2 (member.php)
ES (1) ES2210235T3 (member.php)
TW (1) TW239147B (member.php)
WO (1) WO1993015193A1 (member.php)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5610009A (en) * 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
EP1845108A3 (en) 1994-07-29 2007-10-24 Innogenetics N.V. Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
US6235888B1 (en) * 1994-10-05 2001-05-22 The General Hospital Corporation Hepatitis C virus vaccine
EP0789563B8 (en) * 1994-10-05 2004-11-17 Apollon, Inc. Hepatitis virus b and c vaccines
RU2189254C2 (ru) * 1995-06-06 2002-09-20 Америкэн Хоум Продактс Корпорэйшн Вакцины против вирусов гепатита
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7235394B1 (en) 1995-08-29 2007-06-26 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US7049428B1 (en) * 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
EP0947525A1 (en) 1998-03-27 1999-10-06 Innogenetics N.V. Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
US7108855B2 (en) 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
DE19856261C1 (de) 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
AR029851A1 (es) * 2000-07-21 2003-07-16 Dendreon Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
MXPA03000626A (es) * 2000-07-21 2004-07-30 Schering Corp Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
US7244721B2 (en) * 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
MY143322A (en) * 2000-07-21 2011-04-15 Schering Corp Peptides as ns3-serine protease inhibitors of hepatitis c virus
US7101561B2 (en) 2000-12-01 2006-09-05 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US6673698B1 (en) 2002-01-19 2004-01-06 Megic Corporation Thin film semiconductor package utilizing a glass substrate with composite polymer/metal interconnect layers
TW503496B (en) 2001-12-31 2002-09-21 Megic Corp Chip packaging structure and manufacturing process of the same
TW544882B (en) 2001-12-31 2003-08-01 Megic Corp Chip package structure and process thereof
TW584950B (en) 2001-12-31 2004-04-21 Megic Corp Chip packaging structure and process thereof
WO2009020628A1 (en) * 2007-08-06 2009-02-12 Epiphany Biosciences, Inc. Diagnosis of kaposi's sarcoma-associated herpesvirus (kshv) infection
EP2449381A1 (en) 2009-06-30 2012-05-09 Abbott Laboratories Markers of xmrv infection and uses thereof
CA2769879C (en) 2009-08-28 2015-06-09 Tokyo Metropolitan Institute Of Medical Science Polynucleotide derived from novel hepatitis c virus strain and use thereof
CN109232721B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段418-429及其用途
WO2021252904A1 (en) * 2020-06-11 2021-12-16 Massachusetts Institute Of Technology Ribonucleoprotein approach to boost the sting signaling for cancer immunotherapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
DE3886363T3 (de) * 1987-11-18 2004-09-09 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville NANBV-Diagnostika
UA50829C2 (uk) * 1989-03-17 2002-11-15 Чірон Корпорейшн Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл
US5308750A (en) * 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
SK286106B6 (sk) * 1990-11-08 2008-03-05 Novartis Vaccines & Diagnostics, Inc. Spôsob vykonávania imunodiagnostickej skúšky na detekciu protilátky proti vírusu hepatitídy C

Also Published As

Publication number Publication date
ES2210235T3 (es) 2004-07-01
US5854001A (en) 1998-12-29
JPH07503614A (ja) 1995-04-20
DE69333269T2 (de) 2004-07-29
CA2129733A1 (en) 1993-08-01
TW239147B (member.php) 1995-01-21
WO1993015193A1 (en) 1993-08-05
EP0627000A1 (en) 1994-12-07
CA2129733C (en) 2006-10-31
DE69333269D1 (de) 2003-12-04
AU3604993A (en) 1993-09-01
US5667992A (en) 1997-09-16
EP0627000B1 (en) 2003-10-29
JP3439209B2 (ja) 2003-08-25
EP0627000A4 (en) 1997-07-02

Similar Documents

Publication Publication Date Title
AU666176B2 (en) Mammalian expression systems for HCV proteins
DK2788478T3 (en) Multiplex IMMUNSCREENINGSASSAY
US6635257B1 (en) Particles of HCV envelope proteins: use for vaccination
US6773920B1 (en) Delivery of functional protein sequences by translocating polypeptides
AU2018281889B2 (en) Recombinant measles virus expressing Zika virus proteins and their applications
WO1995020664A9 (en) Mammalian expression systems for hepatitis c virus envelope genes
WO1995020664A2 (en) Mammalian expression systems for hepatitis c virus envelope genes
KR20160002880A (ko) 엔도솜 포집을 극복하기 위해 설계된 인공 전사 인자
SK9996A3 (en) Vaccine preparations
CN112679617B (zh) 一种基于间皮素锚定的哺乳动物融合蛋白展示质粒、细胞系及应用
CN114786685B (zh) 一种基于线粒体的药物递送系统及其用途
CA2392527A1 (en) Hbv/hcv virus-like particle
CN101875692A (zh) 中国仓鼠凋亡相关基因
CN100338219C (zh) 成视网膜细胞瘤蛋白的组织特异性表达
CN101760475B (zh) 重组逆转录病毒载体
CN109929847A (zh) 一种pex26基因、蛋白及其应用
CN111727244B (zh) 循环肿瘤细胞的通用检测探针
CN109735569B (zh) 一种三分子荧光互补蛋白质作用感受器表达系统及其制备方法与应用
CN107805627B (zh) 特异性示踪内皮细胞分化的hESC指示细胞系的构建方法
JP2001299355A (ja) 日本脳炎ウイルス遺伝子をコードするｃＤＮＡを含む発現ベクターおよびそれを用いたワクチン
JP2001299336A (ja) ワクチン及び診断用抗原としての安定で毒性のないフラビウイルス様粒子の作製
BRPI0718989A2 (pt) Ablação genética de células com gene prp usando uma estratégia de captura de promotor direcionada para a produção de proteínas recombinantes isentas de soro como produtos terapêuticos.
CN102051378A (zh) 以病毒mRNA核转运为靶点的抗HIV-1药物筛选方法
AU626007B2 (en) Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins
KR102713784B1 (ko) Tlr2 과발현 죽상동맥경화 동물 모델 및 이의 제조방법